Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosomal protein S15a pseudogene 22 (RPS15AP22; ENSG00000236395) is a nonfunctional genomic DNA segment that closely resembles the functional RPS15A gene which encodes a component of the 40S ribosomal subunit. As a pseudogene, RPS15AP22 has lost its protein-coding ability and does not contribute to ribosome structure or function. There is no evidence for clinical relevance, biomarker utility, or therapeutic targeting of this locus. Pseudogenes like RPS15AP22 are widespread in the genome and generally do not encode functional protein products. While a few pseudogenes have regulatory functions or roles in RNA-based regulation in some settings, most, including RPS15AP22, have no described biological or disease-associated function and are not therapeutic targets. These sequences typically serve as markers of genomic evolution rather than as actionable drug targets. No standard drugs, disease associations, or safety concerns are known for this gene. Their annotation sometimes causes confusion in bioinformatics or genetic studies due to sequence similarity with functional genes.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 22 (RPS15AP22).